Foundayo, Pricing Pressure and the Distribution Wildcard: A Trade Plan on Eli Lilly (LLY)
Eli Lilly's Foundayo approval is a structural positive for its obesity/weight-loss franchise, but near-term headline risk and pricing pressure in markets like India are already showing. I lay out a long trade that assumes disciplined launch execution and controlled margin impact, with a clear entry at $940.06, a stop at $880.00 and a target of $1,1…